tisotumab vedotin,pembrolizumab
genmab,merck,seagen
['gyn', 'engot cx8', 'pembro']
gyn oral abstracts #asco22 #gyncsm vergote
tisotumab vedotin + pembrolizumab (1l) recurrent or metastatic cervical cancer engot cx8/gog 3024/innovatv 205.
*tv + pembro demonstrated encouraging, durable antitumor activity with a manageable and acceptable safety profile 
#ovca survivor; research advocate; author; co-moderator #gyncsm chat;  #ASCO22 Feature Voice  COI: https://t.co/AUF1EprNVt Opinions are my own.